Pharmacokinetics of the Dietary Supplement Creatine View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-05

AUTHORS

Adam M. Persky, Gayle A. Brazeau, Günther Hochhaus

ABSTRACT

Creatine is a nonessential dietary component that, when supplemented in the diet, has shown physiological benefits in athletes, in animal-based models of disease and in patients with various muscle, neurological and neuromuscular disease. The clinical relevance of creatine supplementation is based primarily on its role in ATP generation, and cells may be able to better handle rapidly changing energy demands with supplementation.Although the pharmacological outcome measures of creatine have been investigated, the behaviour of creatine in the blood and muscle is still not fully understood. Creatine is most probably actively absorbed from the gastrointestinal tract in a similar way to amino acids and peptides. The distribution of creatine throughout the body is largely determined by the presence of creatine transporters. These transporters not only serve to distribute creatine but serve as a clearance mechanism because of creatine ‘trapping’ by skeletal muscle. Besides the pseudo-irreversible uptake by skeletal muscle, creatine clearance also depends on renal elimination and degradation to creatinine.Evidence suggests that creatine pharmacokinetics are nonlinear with respect to dose size and frequency. Skeletal muscle, the largest depot of creatine, has a finite capacity to store creatine. As such, when these stores are saturated, both volume of distribution and clearance can decrease, thus leading to complex pharmacokinetic situations. Additionally, other dietary components such as caffeine and carbohydrate can potentially affect pharmacokinetics by their influence on the creatine transporter. Disease and age may also affect the pharmacokinetics, but more information is needed.Overall, there are very limited pharmacokinetic data available for creatine, and further studies are needed to define absorption characteristics, clearance kinetics and the effect of multiple doses. Additionally, the relationship between plasma creatine and muscle creatine needs to be elucidated to optimise administration regimens. More... »

PAGES

557-574

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/00003088-200342060-00005

DOI

http://dx.doi.org/10.2165/00003088-200342060-00005

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1020881996

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12793840


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Absorption", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Caffeine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Creatine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dietary Carbohydrates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dietary Supplements", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Interactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Membrane Transport Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metabolic Clearance Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Muscle, Skeletal", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA", 
          "id": "http://www.grid.ac/institutes/grid.15276.37", 
          "name": [
            "Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Persky", 
        "givenName": "Adam M.", 
        "id": "sg:person.01135500744.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135500744.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy Practice and Pharmaceutics, State University of New York at Buffalo, Amherst, New York, USA", 
          "id": "http://www.grid.ac/institutes/grid.273335.3", 
          "name": [
            "Department of Pharmacy Practice and Pharmaceutics, State University of New York at Buffalo, Amherst, New York, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brazeau", 
        "givenName": "Gayle A.", 
        "id": "sg:person.0677723417.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677723417.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA", 
          "id": "http://www.grid.ac/institutes/grid.15276.37", 
          "name": [
            "Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hochhaus", 
        "givenName": "G\u00fcnther", 
        "id": "sg:person.012057046724.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012057046724.28"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1023/a:1011908606819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039134085", 
          "https://doi.org/10.1023/a:1011908606819"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/6568", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008005540", 
          "https://doi.org/10.1038/6568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s004210050291", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038282020", 
          "https://doi.org/10.1007/s004210050291"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1203/00006450-199409000-00023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006902550", 
          "https://doi.org/10.1203/00006450-199409000-00023"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1006895414925", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021072139", 
          "https://doi.org/10.1023/a:1006895414925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s004210050570", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050465740", 
          "https://doi.org/10.1007/s004210050570"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s004210000370", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035231666", 
          "https://doi.org/10.1007/s004210000370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00225844", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051443591", 
          "https://doi.org/10.1007/bf00225844"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-05", 
    "datePublishedReg": "2003-05-01", 
    "description": "Creatine is a nonessential dietary component that, when supplemented in the diet, has shown physiological benefits in athletes, in animal-based models of disease and in patients with various muscle, neurological and neuromuscular disease. The clinical relevance of creatine supplementation is based primarily on its role in ATP generation, and cells may be able to better handle rapidly changing energy demands with supplementation.Although the pharmacological outcome measures of creatine have been investigated, the behaviour of creatine in the blood and muscle is still not fully understood. Creatine is most probably actively absorbed from the gastrointestinal tract in a similar way to amino acids and peptides. The distribution of creatine throughout the body is largely determined by the presence of creatine transporters. These transporters not only serve to distribute creatine but serve as a clearance mechanism because of creatine \u2018trapping\u2019 by skeletal muscle. Besides the pseudo-irreversible uptake by skeletal muscle, creatine clearance also depends on renal elimination and degradation to creatinine.Evidence suggests that creatine pharmacokinetics are nonlinear with respect to dose size and frequency. Skeletal muscle, the largest depot of creatine, has a finite capacity to store creatine. As such, when these stores are saturated, both volume of distribution and clearance can decrease, thus leading to complex pharmacokinetic situations. Additionally, other dietary components such as caffeine and carbohydrate can potentially affect pharmacokinetics by their influence on the creatine transporter. Disease and age may also affect the pharmacokinetics, but more information is needed.Overall, there are very limited pharmacokinetic data available for creatine, and further studies are needed to define absorption characteristics, clearance kinetics and the effect of multiple doses. Additionally, the relationship between plasma creatine and muscle creatine needs to be elucidated to optimise administration regimens.", 
    "genre": "article", 
    "id": "sg:pub.10.2165/00003088-200342060-00005", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1085321", 
        "issn": [
          "0312-5963", 
          "1179-1926"
        ], 
        "name": "Clinical Pharmacokinetics", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "42"
      }
    ], 
    "keywords": [
      "skeletal muscle", 
      "dietary components", 
      "creatine transporter", 
      "limited pharmacokinetic data", 
      "volume of distribution", 
      "nonessential dietary components", 
      "distribution of creatine", 
      "creatine clearance", 
      "creatine supplementation", 
      "multiple doses", 
      "renal elimination", 
      "outcome measures", 
      "gastrointestinal tract", 
      "plasma creatine", 
      "pharmacokinetic data", 
      "clinical relevance", 
      "neuromuscular disease", 
      "muscle creatine", 
      "clearance mechanisms", 
      "pharmacokinetics", 
      "clearance kinetics", 
      "animal-based models", 
      "creatine", 
      "muscle", 
      "disease", 
      "Further studies", 
      "physiological benefits", 
      "supplementation", 
      "clearance", 
      "large depots", 
      "ATP generation", 
      "transporters", 
      "patients", 
      "creatinine", 
      "doses", 
      "administration", 
      "blood", 
      "tract", 
      "diet", 
      "age", 
      "amino acids", 
      "athletes", 
      "caffeine", 
      "cells", 
      "more information", 
      "depots", 
      "peptides", 
      "uptake", 
      "evidence", 
      "elimination", 
      "study", 
      "role", 
      "benefits", 
      "measures", 
      "carbohydrates", 
      "relevance", 
      "stores", 
      "effect", 
      "volume", 
      "presence", 
      "acid", 
      "body", 
      "mechanism", 
      "similar way", 
      "frequency", 
      "data", 
      "components", 
      "relationship", 
      "capacity", 
      "characteristics", 
      "information", 
      "distribution", 
      "size", 
      "influence", 
      "situation", 
      "model", 
      "respect", 
      "generation", 
      "kinetics", 
      "absorption characteristics", 
      "behavior", 
      "degradation", 
      "way", 
      "demand", 
      "trapping", 
      "energy demand", 
      "finite capacity"
    ], 
    "name": "Pharmacokinetics of the Dietary Supplement Creatine", 
    "pagination": "557-574", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1020881996"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/00003088-200342060-00005"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12793840"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/00003088-200342060-00005", 
      "https://app.dimensions.ai/details/publication/pub.1020881996"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-06-01T22:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_378.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.2165/00003088-200342060-00005"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/00003088-200342060-00005'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/00003088-200342060-00005'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/00003088-200342060-00005'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/00003088-200342060-00005'


 

This table displays all metadata directly associated to this object as RDF triples.

258 TRIPLES      22 PREDICATES      137 URIs      121 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/00003088-200342060-00005 schema:about N0097b44c93ae4929a72a0985cc3ef0e1
2 N021652a33188409381f2d81bc5c41ad6
3 N05a581d9614444bf8fc39217bbc883c1
4 N0e6eb3c25ca1404392a5411422d5521d
5 N139a7bb977584071adacadce618528d3
6 N30fad081f8144751a68594746caf19c9
7 N55c12424b1bc424f9104c75371fd12c5
8 N5b844ff7b00049a3885d97e107cddafd
9 N803c11efbe884965a04952cb6398a0b2
10 N85bdc3f79b7d44ae89e98774cecb998e
11 Nac5ff75baf1644a4b1687ef5045327cf
12 Ne0443b676f2e49c9a2588e6e6573b517
13 Nf33dcbb28b9c426ca67bdd29ff5e7c0e
14 Nfb323617451e4e6bbe6084e888cbbdf9
15 Nfb7f546eb0d24b6ca4b47ab900e8d9ba
16 anzsrc-for:11
17 anzsrc-for:1115
18 schema:author N8ca5294a7cf24e9591e56be94e2ade4f
19 schema:citation sg:pub.10.1007/bf00225844
20 sg:pub.10.1007/s004210000370
21 sg:pub.10.1007/s004210050291
22 sg:pub.10.1007/s004210050570
23 sg:pub.10.1023/a:1006895414925
24 sg:pub.10.1023/a:1011908606819
25 sg:pub.10.1038/6568
26 sg:pub.10.1203/00006450-199409000-00023
27 schema:datePublished 2003-05
28 schema:datePublishedReg 2003-05-01
29 schema:description Creatine is a nonessential dietary component that, when supplemented in the diet, has shown physiological benefits in athletes, in animal-based models of disease and in patients with various muscle, neurological and neuromuscular disease. The clinical relevance of creatine supplementation is based primarily on its role in ATP generation, and cells may be able to better handle rapidly changing energy demands with supplementation.Although the pharmacological outcome measures of creatine have been investigated, the behaviour of creatine in the blood and muscle is still not fully understood. Creatine is most probably actively absorbed from the gastrointestinal tract in a similar way to amino acids and peptides. The distribution of creatine throughout the body is largely determined by the presence of creatine transporters. These transporters not only serve to distribute creatine but serve as a clearance mechanism because of creatine ‘trapping’ by skeletal muscle. Besides the pseudo-irreversible uptake by skeletal muscle, creatine clearance also depends on renal elimination and degradation to creatinine.Evidence suggests that creatine pharmacokinetics are nonlinear with respect to dose size and frequency. Skeletal muscle, the largest depot of creatine, has a finite capacity to store creatine. As such, when these stores are saturated, both volume of distribution and clearance can decrease, thus leading to complex pharmacokinetic situations. Additionally, other dietary components such as caffeine and carbohydrate can potentially affect pharmacokinetics by their influence on the creatine transporter. Disease and age may also affect the pharmacokinetics, but more information is needed.Overall, there are very limited pharmacokinetic data available for creatine, and further studies are needed to define absorption characteristics, clearance kinetics and the effect of multiple doses. Additionally, the relationship between plasma creatine and muscle creatine needs to be elucidated to optimise administration regimens.
30 schema:genre article
31 schema:inLanguage en
32 schema:isAccessibleForFree false
33 schema:isPartOf N941eea368b114307b83bf206e5b27efb
34 Nebcad85cfca34232b5d36ce22b2db90e
35 sg:journal.1085321
36 schema:keywords ATP generation
37 Further studies
38 absorption characteristics
39 acid
40 administration
41 age
42 amino acids
43 animal-based models
44 athletes
45 behavior
46 benefits
47 blood
48 body
49 caffeine
50 capacity
51 carbohydrates
52 cells
53 characteristics
54 clearance
55 clearance kinetics
56 clearance mechanisms
57 clinical relevance
58 components
59 creatine
60 creatine clearance
61 creatine supplementation
62 creatine transporter
63 creatinine
64 data
65 degradation
66 demand
67 depots
68 diet
69 dietary components
70 disease
71 distribution
72 distribution of creatine
73 doses
74 effect
75 elimination
76 energy demand
77 evidence
78 finite capacity
79 frequency
80 gastrointestinal tract
81 generation
82 influence
83 information
84 kinetics
85 large depots
86 limited pharmacokinetic data
87 measures
88 mechanism
89 model
90 more information
91 multiple doses
92 muscle
93 muscle creatine
94 neuromuscular disease
95 nonessential dietary components
96 outcome measures
97 patients
98 peptides
99 pharmacokinetic data
100 pharmacokinetics
101 physiological benefits
102 plasma creatine
103 presence
104 relationship
105 relevance
106 renal elimination
107 respect
108 role
109 similar way
110 situation
111 size
112 skeletal muscle
113 stores
114 study
115 supplementation
116 tract
117 transporters
118 trapping
119 uptake
120 volume
121 volume of distribution
122 way
123 schema:name Pharmacokinetics of the Dietary Supplement Creatine
124 schema:pagination 557-574
125 schema:productId N012d32373a50456d847ea45408243f7a
126 N12c2ed7cf83242609f0f9080d4c9dc87
127 N1f3c07153cad4b859cfe883b88388d1c
128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020881996
129 https://doi.org/10.2165/00003088-200342060-00005
130 schema:sdDatePublished 2022-06-01T22:04
131 schema:sdLicense https://scigraph.springernature.com/explorer/license/
132 schema:sdPublisher N0357c67224ce497bbadc3412e7b0dcac
133 schema:url https://doi.org/10.2165/00003088-200342060-00005
134 sgo:license sg:explorer/license/
135 sgo:sdDataset articles
136 rdf:type schema:ScholarlyArticle
137 N0097b44c93ae4929a72a0985cc3ef0e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Male
139 rdf:type schema:DefinedTerm
140 N012d32373a50456d847ea45408243f7a schema:name doi
141 schema:value 10.2165/00003088-200342060-00005
142 rdf:type schema:PropertyValue
143 N021652a33188409381f2d81bc5c41ad6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Animals
145 rdf:type schema:DefinedTerm
146 N0357c67224ce497bbadc3412e7b0dcac schema:name Springer Nature - SN SciGraph project
147 rdf:type schema:Organization
148 N05a581d9614444bf8fc39217bbc883c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Administration, Oral
150 rdf:type schema:DefinedTerm
151 N0e6eb3c25ca1404392a5411422d5521d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Drug Interactions
153 rdf:type schema:DefinedTerm
154 N12c2ed7cf83242609f0f9080d4c9dc87 schema:name dimensions_id
155 schema:value pub.1020881996
156 rdf:type schema:PropertyValue
157 N139a7bb977584071adacadce618528d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Kidney
159 rdf:type schema:DefinedTerm
160 N1f3c07153cad4b859cfe883b88388d1c schema:name pubmed_id
161 schema:value 12793840
162 rdf:type schema:PropertyValue
163 N30fad081f8144751a68594746caf19c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Muscle, Skeletal
165 rdf:type schema:DefinedTerm
166 N55c12424b1bc424f9104c75371fd12c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Humans
168 rdf:type schema:DefinedTerm
169 N5b844ff7b00049a3885d97e107cddafd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Female
171 rdf:type schema:DefinedTerm
172 N803c11efbe884965a04952cb6398a0b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Membrane Transport Proteins
174 rdf:type schema:DefinedTerm
175 N85bdc3f79b7d44ae89e98774cecb998e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Creatine
177 rdf:type schema:DefinedTerm
178 N8ca5294a7cf24e9591e56be94e2ade4f rdf:first sg:person.01135500744.17
179 rdf:rest Na6419a247b5a438dbe2ef442e34c54e6
180 N941eea368b114307b83bf206e5b27efb schema:volumeNumber 42
181 rdf:type schema:PublicationVolume
182 Na6419a247b5a438dbe2ef442e34c54e6 rdf:first sg:person.0677723417.90
183 rdf:rest Ncb0fc95a71114e05a090592be69ed38e
184 Nac5ff75baf1644a4b1687ef5045327cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Absorption
186 rdf:type schema:DefinedTerm
187 Ncb0fc95a71114e05a090592be69ed38e rdf:first sg:person.012057046724.28
188 rdf:rest rdf:nil
189 Ne0443b676f2e49c9a2588e6e6573b517 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Dietary Carbohydrates
191 rdf:type schema:DefinedTerm
192 Nebcad85cfca34232b5d36ce22b2db90e schema:issueNumber 6
193 rdf:type schema:PublicationIssue
194 Nf33dcbb28b9c426ca67bdd29ff5e7c0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Caffeine
196 rdf:type schema:DefinedTerm
197 Nfb323617451e4e6bbe6084e888cbbdf9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Metabolic Clearance Rate
199 rdf:type schema:DefinedTerm
200 Nfb7f546eb0d24b6ca4b47ab900e8d9ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Dietary Supplements
202 rdf:type schema:DefinedTerm
203 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
204 schema:name Medical and Health Sciences
205 rdf:type schema:DefinedTerm
206 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
207 schema:name Pharmacology and Pharmaceutical Sciences
208 rdf:type schema:DefinedTerm
209 sg:journal.1085321 schema:issn 0312-5963
210 1179-1926
211 schema:name Clinical Pharmacokinetics
212 schema:publisher Springer Nature
213 rdf:type schema:Periodical
214 sg:person.01135500744.17 schema:affiliation grid-institutes:grid.15276.37
215 schema:familyName Persky
216 schema:givenName Adam M.
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135500744.17
218 rdf:type schema:Person
219 sg:person.012057046724.28 schema:affiliation grid-institutes:grid.15276.37
220 schema:familyName Hochhaus
221 schema:givenName Günther
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012057046724.28
223 rdf:type schema:Person
224 sg:person.0677723417.90 schema:affiliation grid-institutes:grid.273335.3
225 schema:familyName Brazeau
226 schema:givenName Gayle A.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677723417.90
228 rdf:type schema:Person
229 sg:pub.10.1007/bf00225844 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051443591
230 https://doi.org/10.1007/bf00225844
231 rdf:type schema:CreativeWork
232 sg:pub.10.1007/s004210000370 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035231666
233 https://doi.org/10.1007/s004210000370
234 rdf:type schema:CreativeWork
235 sg:pub.10.1007/s004210050291 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038282020
236 https://doi.org/10.1007/s004210050291
237 rdf:type schema:CreativeWork
238 sg:pub.10.1007/s004210050570 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050465740
239 https://doi.org/10.1007/s004210050570
240 rdf:type schema:CreativeWork
241 sg:pub.10.1023/a:1006895414925 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021072139
242 https://doi.org/10.1023/a:1006895414925
243 rdf:type schema:CreativeWork
244 sg:pub.10.1023/a:1011908606819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039134085
245 https://doi.org/10.1023/a:1011908606819
246 rdf:type schema:CreativeWork
247 sg:pub.10.1038/6568 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008005540
248 https://doi.org/10.1038/6568
249 rdf:type schema:CreativeWork
250 sg:pub.10.1203/00006450-199409000-00023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006902550
251 https://doi.org/10.1203/00006450-199409000-00023
252 rdf:type schema:CreativeWork
253 grid-institutes:grid.15276.37 schema:alternateName Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA
254 schema:name Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA
255 rdf:type schema:Organization
256 grid-institutes:grid.273335.3 schema:alternateName Department of Pharmacy Practice and Pharmaceutics, State University of New York at Buffalo, Amherst, New York, USA
257 schema:name Department of Pharmacy Practice and Pharmaceutics, State University of New York at Buffalo, Amherst, New York, USA
258 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...